Hitachi Chemical Advanced Therapeutics Solutions and Ori Biotech Announce a Joint Development Agreement to Advance Innovation in Cell Therapy Manufacturing

SourceYahoo Finance
Date Published01/21/2020
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Hitachi Chemical Advanced Therapeutic Solutions
Parent companyHitachi Chemical Company, Ltd.
Type of work Manufacturing
If manufacturing, is the company a contract manufacturer?Yes
Reshoring category:Foreign Direct Investment
Year reshoring announced:2020
Country(ies) from which reshored:Japan
City reshored to:Allendale
State(s) reshored to:NJ
If relevant, work nearshored to:-
Product(s) reshoredcell and gene therapy products
What domestic positive factors made reshoring more attractive?Automation/technology, Customer responsiveness improvement, Proximity to customers/market, Other, partnership
Find Reshoring Articles